Eli Lilly and NVIDIA Partnership
Eli Lilly and NVIDIA are collaborating to build a new supercomputer, aiming to accelerate drug discovery and shorten development cycles.
This partnership is part of a growing trend of AI-centric projects in the pharmaceutical industry, marking one of the largest AI partnerships to date.
Supercomputer Details
The supercomputer will be powered by over a thousand graphics processing units (GPUs) and will serve as an "AI factory", managing the entire AI lifecycle.
It will run on renewable electricity and be housed within Lilly facilities.
The supercomputer is considered pharma's "most powerful" and will significantly impact the industry.
Industry Impact
The partnership combines business intelligence and editorial excellence, reaching engaged professionals across 36 leading media platforms.
Author's summary: Eli Lilly and NVIDIA build pharma's most powerful supercomputer.
More News
- Colonizers Torch Vehicles in Burqa Amid Daily Attacks, Land Seizures
- Israeli Colonizers Invade Bedouin Village Near Jerusalem
- Thursday: Invasions, Violations, and Abductions Across West Bank
- Pashinyan Confident Armenians Will Support Peace Process in 2026 Parliamentary Election
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men
- CDEDI urges MPs to prioritize citizens’ interests new parliamentary term Malawi 24 | Latest News from Malawi
- Prime Minister Pashinyan should be excommunicated and arrested
- An Obscure Military Program Helps Local Cops Buy Armored Cars and Spyware. It Might Balloon Under Trump.
- Uzbekistan pitches worldwide initiatives at UNESCO General Conference
- Record Job Cuts at Amazon and UPS. AI and Reorganization Changing the Face of Logistics